Hsbc Holdings PLC Has $546,000 Stock Holdings in HealthEquity, Inc. $HQY

Hsbc Holdings PLC trimmed its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 74.5% in the 4th quarter, HoldingsChannel reports. The firm owned 5,951 shares of the company’s stock after selling 17,362 shares during the quarter. Hsbc Holdings PLC’s holdings in HealthEquity were worth $546,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HQY. William Blair Investment Management LLC purchased a new position in HealthEquity in the 4th quarter worth about $169,956,000. Norges Bank purchased a new stake in HealthEquity during the fourth quarter valued at about $66,927,000. AQR Capital Management LLC boosted its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the period. Millennium Management LLC boosted its holdings in shares of HealthEquity by 151.5% in the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after buying an additional 573,283 shares during the period. Finally, Cadian Capital Management LP purchased a new position in shares of HealthEquity in the fourth quarter worth approximately $51,915,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Finally, Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $110.57.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by company insiders.

HealthEquity Trading Up 3.8%

NASDAQ:HQY opened at $98.69 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The stock’s 50-day moving average is $88.50 and its two-hundred day moving average is $84.69. The stock has a market cap of $8.25 billion, a PE ratio of 36.96, a price-to-earnings-growth ratio of 1.60 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.